Literature DB >> 20010128

Age-related differences in exercise and quality of life among breast cancer survivors.

Sheree A Harrison1, Sandra C Hayes, Beth Newman.   

Abstract

PURPOSE: Physical activity has become a focus of cancer recovery research because it has the potential to reduce treatment-related burden and to optimize health-related quality of life (HRQoL). However, the potential for physical activity to influence recovery may be age dependent. This article describes physical activity levels and HRQoL among younger and older women after surgery for breast cancer and explores the correlates of physical inactivity.
METHODS: A population-based sample of breast cancer patients (n = 287) diagnosed in South-East Queensland, Australia, were assessed once every 3 months, from 6 to 18 months postsurgery. The Functional Assessment of Cancer Therapy-Breast questionnaire and items from the Behavioral Risk Factor Surveillance System questionnaire were used to measure HRQoL and physical activity, respectively. Physical activity was assigned MET values and categorized as <3, 3 to 17.9, and 18+ MET x h x wk. Descriptive statistics, generalized linear models with age stratification (<50 vs 50+ yr), and logistic regression were used for analyses (P = 0.05, two-tailed).
RESULTS: Younger women who engaged in >or=3 MET x h x wk of physical activity reported a higher HRQoL at 18 months compared with their more sedentary counterparts (P < 0.05). Older women reported similar HRQoL irrespective of activity level and consistently reported clinically higher HRQoL than younger women. Increasing age, being overweight or obese, and restricting use of the treated side at 6 months postsurgery increased the likelihood of sedentary behavior (odds ratio >or= 3, P < 0.05).
CONCLUSIONS: Age influences the potential to observe HRQoL benefits related to physical activity participation. These results also provide relevant information for the design of exercise interventions for breast cancer survivors and highlight that some groups of women are at greater risk of long-term sedentary behavior.

Entities:  

Mesh:

Year:  2010        PMID: 20010128     DOI: 10.1249/MSS.0b013e3181b0f2cb

Source DB:  PubMed          Journal:  Med Sci Sports Exerc        ISSN: 0195-9131            Impact factor:   5.411


  5 in total

1.  Factors Influencing Exercise Following Pancreatic Tumor Resection.

Authors:  Nathan H Parker; Karen Basen-Engquist; M Laura Rubin; Yisheng Li; Laura Prakash; An Ngo-Huang; Jessica Gorzelitz; Naruhiko Ikoma; Jeffrey E Lee; Matthew H G Katz
Journal:  Ann Surg Oncol       Date:  2020-09-04       Impact factor: 5.344

2.  Get Healthy after Breast Cancer - examining the feasibility, acceptability and outcomes of referring breast cancer survivors to a general population telephone-delivered program targeting physical activity, healthy diet and weight loss.

Authors:  S Lawler; G Maher; M Brennan; A Goode; M M Reeves; E Eakin
Journal:  Support Care Cancer       Date:  2017-02-04       Impact factor: 3.603

3.  Municipality-based pragmatic rehabilitation stratified in accordance with individual needs-results from a longitudinal survey study.

Authors:  Sine Rossen; Karen Trier; Berit Christensen; Martina A Eriksen; Ann-Dorthe Zwisler; Jette Vibe-Petersen
Journal:  Support Care Cancer       Date:  2019-08-02       Impact factor: 3.603

4.  Telehealth system (e-CUIDATE) to improve quality of life in breast cancer survivors: rationale and study protocol for a randomized clinical trial.

Authors:  Noelia Galiano-Castillo; Angelica Ariza-García; Irene Cantarero-Villanueva; Carolina Fernández-Lao; Lourdes Díaz-Rodríguez; Marta Legerén-Alvarez; Carmen Sánchez-Salado; Rosario Del-Moral-Avila; Manuel Arroyo-Morales
Journal:  Trials       Date:  2013-06-22       Impact factor: 2.279

5.  Effectiveness of Combined Smartwatch and Social Media Intervention on Breast Cancer Survivor Health Outcomes: A 10-Week Pilot Randomized Trial.

Authors:  Zachary C Pope; Nan Zeng; Rui Zhang; Hee Yun Lee; Zan Gao
Journal:  J Clin Med       Date:  2018-06-07       Impact factor: 4.241

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.